Ripples maintain time-locked occurrence across the septo-temporal axis and hemispheres while showing local phase coupling, revealing a dual mode of synchrony in CA1 network dynamics.
OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral ...
The Phase 1b study is designed to evaluate the safety and tolerability of orally administered balomenib over a 28-day treatment period, followed by a post-treatment observation phase of up to ...
A Brazilian study has confirmed that Joseph’s Coat, a plant used for generations in folk medicine, can significantly reduce inflammation and arthritis symptoms in lab tests. Researchers observed less ...
Scientists at the University of Oxford demonstrate an approach to interpreting how materials interact with polarized light, ...
Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...
Non-terrestrial networks, combined with early 6G research, demand test equipment capable of handling extreme parameters and ...
Peptinov today announced the publication of the Phase 1 clinical results for PPV-06, its first-in-class active immunotherapy targeting IL-6, in the peer-reviewed journal Nature Communications. The ...
The latest announcement is out from Ovid Therapeutics ( (OVID) ).
Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic ...
Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...
The trial narrowly missed its primary endpoint; however, Oppenheimer highlighted that omitting four patients with eligibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback